Login to Your Account

Clinic Roundup

Friday, January 11, 2013
• GeoVax Labs Inc., of Atlanta, said it completed enrollment in a nine-patient Phase I/II trial testing its DNA/MVA vaccine to elicit protective immune responses in HIV-infected patients.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription